Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Three SGLT-2 inhibitors are available in the United States: canagliflozin, dapagliflozin, and empagliflozin. All 3 are brand-name, are administered orally once daily, and lead to similar hemoglobin A1c...
This article reviews the different expert guidelines for controlling hemoglobin A1c, LDL cholesterol, and blood pressure in patients with diabetes and offers suggestions for sorting out the confusion.
In shared decision-making (SDM), clinicians, diabetes educators, and other members of the health care team elicit perspectives and priorities of the patient and present options and information so that the...
A 49-year-old man with a history of diabetes mellitus, tuberculosis, and herpes simplex keratitis presented from a dermatology clinic with a 2-month history of a progressively worsening blistering rash. ...